Docosahexaenoic Acid on Breath Holding Spells in Children

ConditionBreath Holding Attack

Trial statusRecruiting

Trial phasePhase 3

Trial typeInterventional

Biological sexAll

Age1-5

SponsorSherief Abd-Elsalam

About this trial

DHA on Breath Holding Spells

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Children with newly diagnosed sprlls

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

DHA
Drug
Docosahexaenoic acid
Placebo
Drug
Placebo

Treatment groups

60 Participants

are divided into 2 treatment groups

Group A: Docosahexaenoic AcidExperimental treatment 1 intervention

Group B: Placebo drugPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

Frequency of the spells

Number of attacks

Time frame

6 months

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Sherief Abd-Elsalam

Lead sponsor

Tanta University

Sponsor institution

Source ClinicalTrials.gov

Apply now